- Home
- RMTI vs YI Comparison
RMTI vs YI Comparison
Compare RMTI & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- YI
- Stock Information
- Founded
- RMTI 1994
- YI 2010
- Country
- RMTI United States
- YI China
- Employees
- RMTI N/A
- YI N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- RMTI Health Care
- YI Consumer Staples
- Exchange
- RMTI Nasdaq
- YI Nasdaq
- Market Cap
- RMTI 71.1M
- YI 68.5M
- IPO Year
- RMTI 1998
- YI N/A
- Fundamental
- Price
- RMTI $1.77
- YI $8.36
- Analyst Decision
- RMTI Strong Buy
- YI
- Analyst Count
- RMTI 2
- YI 0
- Target Price
- RMTI $6.00
- YI N/A
- AVG Volume (30 Days)
- RMTI 266.2K
- YI 45.9K
- Earning Date
- RMTI 03-20-2025
- YI 03-20-2025
- Dividend Yield
- RMTI N/A
- YI N/A
- EPS Growth
- RMTI N/A
- YI N/A
- EPS
- RMTI N/A
- YI N/A
- Revenue
- RMTI $98,917,000.00
- YI $2,090,255,896.00
- Revenue This Year
- RMTI $22.58
- YI $61.85
- Revenue Next Year
- RMTI N/A
- YI N/A
- P/E Ratio
- RMTI N/A
- YI N/A
- Revenue Growth
- RMTI 22.37
- YI N/A
- 52 Week Low
- RMTI $1.23
- YI $0.41
- 52 Week High
- RMTI $5.15
- YI $8.81
- Technical
- Relative Strength Index (RSI)
- RMTI 33.96
- YI 90.30
- Support Level
- RMTI $1.75
- YI $6.88
- Resistance Level
- RMTI $1.97
- YI $8.44
- Average True Range (ATR)
- RMTI 0.10
- YI 0.52
- MACD
- RMTI -0.01
- YI 0.01
- Stochastic Oscillator
- RMTI 5.71
- YI 86.20
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.